The Scientific and Societal Value of Paleoflood Hydrology

2013 ◽  
pp. 1-19 ◽  
Author(s):  
Victor R. Baker ◽  
Robert H. Webb ◽  
P. Kyle House
Keyword(s):  
Societal Value

scholarly journals Forecast Hesitancy: Why are People Reluctant to Believe, Accept, or Respond to Various Weather, Water, and Climate Hazard-Related Forecasts?

2021 ◽  
Author(s):  
Michael H. Glantz ◽  
Gregory E. Pierce
Keyword(s):  
Vaccine Hesitancy ◽  
Social Phenomenon ◽  
Targeted Interventions ◽  
Personal Risk ◽  
Societal Value ◽  
The Social ◽  
The World ◽  
Near Term ◽  
Risk Reducing ◽  
Delayed Responses

AbstractCurrent discussions of the social phenomenon of “vaccine hesitancy” with regard to Covid-19 provide an opportunity to use hesitancy as a means to shift thinking about untimely and delayed responses to forecasts of hydrometeorological hazards. Hesitancy, that is, provides a paradigm through which such regrettably delayed responses to hydromet hazards might be better understood and effectively addressed. Without exaggeration, just about every hydromet event provides an example of how hesitancy hinders individual, community, and national government risk-reducing preventive and mitigative responses to forecasts of foreseeable, relatively near-term climate, water, or weather hazards. Reasons for such hesitancy (for vaccine and forecast use alike) include—among others—lack of trust in the science, lack of confidence in government, and persistent concern about the uncertainties that surround forecasting—both meteorological and public health. As such, a better understanding of the causes that lead to individual and group hesitancy can better inform hydromet forecasters and affected communities about ways in which beneficial actions in response to timely forecasts are often delayed. This better understanding will facilitate, where necessary, targeted interventions to enhance the societal value of forecasting by reducing this long-observed challenge of “forecast hesitancy.” First, this article focuses on incidents of “vaccine hesitancy” that, for various reasons, people around the world are even now experiencing with regard to several now-available, and confirmed efficacious, Covid-19 vaccines. Reports of such incidents of indecisiveness first increased dramatically over the first few months of 2021, despite the strong scientific confidence that vaccination would significantly lower personal risk of contracting as well as spreading the virus. After, the notion of forecast hesitancy with regard to hydrometeorological hazards is discussed.It’s not what you say, it’s what people hear.-Frank Luntz (2007)

Survey Results on Local Markets to Enable Societal Value

2021 ◽  
Author(s):  
Orlando Valarezo ◽  
Jose Pablo Chaves Avila ◽  
Joni Rossi ◽  
Emil Hillberg ◽  
Marco Baron
Keyword(s):  
Local Markets ◽  
Societal Value ◽  
Survey Results

Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?

Health Policy ◽  
2019 ◽  
Vol 123 (2) ◽  
pp. 152-158 ◽  
Author(s):  
J. López-Bastida ◽  
J.M. Ramos-Goñi ◽  
I. Aranda-Reneo ◽  
M. Trapero-Bertran ◽  
P. Kanavos ◽  
...  
Keyword(s):  
Discrete Choice Experiment ◽  
Discrete Choice ◽  
Rare Diseases ◽  
Choice Experiment ◽  
Stated Preference ◽  
Decision Makers ◽  
Societal Value

Ethical Dilemmas in Data Mining and Warehousing

2008 ◽  
pp. 2841-2849
Author(s):  
Joseph A. Cazier ◽  
Ryan C. LaBrie
Keyword(s):  
Data Mining ◽  
Ethical Dilemmas ◽  
Identity Theft ◽  
World Today ◽  
Societal Value ◽  
The World ◽  
Marketing Data

As we have increasing privacy and risk concerns in the world today with identity theft, questionable marketing, data mining, and profiling, it is becoming increasingly important to explore how consumers feel and react to the use of their data. This study makes an important contribution to the literature by presenting common positive and negative myths surrounding these issues and exploring how ethical or unethical consumers believe these practices are by looking at the myths and their reaction to them. We focus on consumers’ perceptions because at the end of the day it is what the consumers perceive to be happing that will determine their reaction. An ethical data practice is one that is believed to increase consumer, business, or societal value, and an unethical data practice is one which causes harm to these groups.

How to define, identify, and measure societal value

2020 ◽  
Author(s):  
Adam Lindgreen ◽  
C. Anthony Di Benedetto ◽  
Ann Højbjerg Clarke ◽  
Majbritt Rostgaard Evald ◽  
Niels Bjørn-Andersen ◽  
...  
Keyword(s):  
Societal Value

Losing a Base of Power through Routinized Rewards

1988 ◽  
Vol 13 (1) ◽  
pp. 63-68 ◽  
Author(s):  
R P Singh ◽  
Janak Pandey
Keyword(s):  
Electronic Equipment ◽  
Questionnaire Study ◽  
Value System ◽  
Organizational Behaviour ◽  
Bases Of Power ◽  
Societal Value ◽  
Organizational Choice ◽  
Equipment Manufacturing

Do Indian organizations use fear of punishment rather than rewarding achievement of extraordinary results, initiative, and enterprise? Have they so routinized employee rewards that they do not use this important instrument for influencing organizational behaviour and processes? Does this organizational choice of the bases of power emanate from our societal value system? Based on a questionnaire study of 250 employees of a large electronic equipment manufacturing public undertaking, Professors R P Singh and Janak Pandey raise these questions for our examination.

scholarly journals Improving patient access to cancer drugs in India: Using economic modeling to estimate a more affordable drug cost based on measures of societal value

2011 ◽  
Vol 27 (1) ◽  
pp. 23-30 ◽  
Author(s):  
George Dranitsaris ◽  
Ilse Truter ◽  
Martie S. Lubbe ◽  
Nitin N. Sriramanakoppa ◽  
Vivian M. Mendonca ◽  
...  
Keyword(s):  
Economic Value ◽  
World Health ◽  
Cancer Drug ◽  
Base Case ◽  
Public Healthcare ◽  
Monthly Cost ◽  
New Drug ◽  
Societal Value ◽  
Life Years ◽  
Per Capita

Background: Using multiples of India's per capita gross domestic product (GDP) as the threshold for economic value as suggested by the World Health Organization (WHO), decision analysis modeling was used to estimate a more affordable monthly cost in India for a hypothetical new cancer drug that provides a 3-month survival benefit to Indian patients with metastatic colorectal cancer (mCRC).Methods: A decision model was developed to simulate progression-free and overall survival in mCRC patients receiving chemotherapy with and without the new drug. Costs for chemotherapy and side-effects management were obtained from both public and private hospitals in India. Utility estimates measured as quality-adjusted life-years (QALY) were determined by interviewing twenty-four oncology nurses using the Time Trade-Off technique. The monthly cost of the new drug was then estimated using a target threshold of US$9,300 per QALY gained, which is three times the Indian per capita GDP.Results: The base-case analysis suggested that a price of US$98.00 per dose would be considered cost-effective from the Indian public healthcare perspective. If the drug were able to improve patient quality of life above the standard of care or survival from 3 to 6 months, the price per dose could increase to US$170 and US$253 and offer the same value.Conclusions: The use of the WHO criteria for estimating the cost of a new drug based on economic value for a developing country like India is feasible and can be used to estimate a more affordable cost based on societal value thresholds.

Antibiotic Development Incentives That Reflect Societal Value of Antibiotics

2020 ◽  
Author(s):  
Helen W Boucher ◽  
Thomas M File ◽  
Vance G Fowler ◽  
Amanda Jezek ◽  
John H Rex ◽  
...  
Keyword(s):  
Antibiotic Development ◽  
Societal Value ◽  
Development Incentives
Sign in / Sign up

Export Citation Format

Share Document